Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
GERN · NASDAQ · Pharmaceutical Preparations
$0.8707−0.0423 (−4.63%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Geron (GERN) · oqro.io/stocks/GERN · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 13, 2026 · Filed Nov 16, 2026
CEO purchased ~$51K of GERN shares in the open marketSourceInsider trade · Traded Nov 16, 2026 · Filed Nov 16, 2026
Officer purchased ~$11K of GERN shares in the open marketSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Deep Track Capital, LP no longer reported GERN for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Ra Capital Management, L.P. disclosed a reduced position in GERN for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Deep Track Capital, LP disclosed a reduced position in GERN for Q1 2026SourceInsider trade · Traded Feb 18, 2026 · Filed Feb 19, 2026
CFO sold ~$19K of GERN shares in the open marketSourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Ra Capital Management, L.P. disclosed an increased position in GERN for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Deep Track Capital, LP disclosed a reduced position in GERN for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Deep Track Capital, LP disclosed a reduced position in GERN for Q3 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Deep Track Capital, LP disclosed an increased position in GERN for Q2 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Holocene Advisors, LP no longer reported GERN for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Deep Track Capital, LP disclosed an increased position in GERN for Q1 2025SourceInsider trade · Traded May 9, 2025 · Filed May 13, 2025
Director purchased ~$16K of GERN shares in the open marketSourceInsider trade · Traded Feb 27, 2025 · Filed Mar 3, 2025
Officer purchased ~$24K of GERN shares in the open marketSourceInsider trade · Traded Feb 27, 2025 · Filed Mar 3, 2025
Officer purchased ~$160K of GERN shares in the open marketSourceInsider trade · Traded Feb 27, 2025 · Filed Mar 3, 2025
CEO purchased ~$22K of GERN shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
RTW Investments, LP no longer reported GERN for Q4 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Feb 14, 2025
Farallon Capital Management, L.L.C. disclosed a reduced position in GERN for Q3 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Deep Track Capital, LP disclosed a reduced position in GERN for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Ra Capital Management, L.P. disclosed a reduced position in GERN for Q4 2024Fund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
RTW Investments, LP disclosed a new position in GERN for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Holocene Advisors, LP disclosed a new position in GERN for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Ra Capital Management, L.P. disclosed a reduced position in GERN for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Deep Track Capital, LP disclosed a reduced position in GERN for Q3 2024Fund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Holocene Advisors, LP disclosed an increased position in GERN for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 11, 2025
Segall Bryant & Hamill, LLC disclosed an increased position in GERN for Q4 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Orbimed Advisors LLC no longer reported GERN for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Eventide Asset Management, LLC disclosed an increased position in GERN for Q3 2024Source